SFG
ITCI

Steward Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Steward Financial Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1K Buy
+38
New +$2.21K ﹤0.01% 1300

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Financial Group's ITCI Position: Q3 2023 in Review

Steward Financial Group opened a new position in Intra-Cellular Therapies Inc. (ITCI) in Q3 2023: 38 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1300 among its holdings.

292 funds tracked by Wall St. Rank hold ITCI as of Q3 2023.

  • Steward Financial Group held 38 shares of Intra-Cellular Therapies Inc. worth $1K as of Q3 2023.
  • Intra-Cellular Therapies Inc. was a new Steward Financial Group position in Q3 2023.
  • Intra-Cellular Therapies Inc. made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1300 holding.
  • 292 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.